Altered DNA methylation profile in idiopathic pulmonary fibrosis.

RATIONALE DNA methylation is an important epigenetic mechanism, which often occurs in response to environmental stimuli and is crucial in regulating gene expression. It is likely that epigenetic alterations contribute to pathogenesis in idiopathic pulmonary fibrosis (IPF). OBJECTIVES To determine the DNA methylation changes in IPF and their effects on gene expression. METHODS Total DNA methylation and DNA methyltransferase expression were compared in IPF and normal control lung tissues. IPF and normal tissues were subjected to comparative analysis of genome-wide DNA methylation and RNA expression using DNA hybridization to the Illumina HumanMethylation27 BeadChip and RNA hybridization to Illumina HumanHT-12 BeadChip. Functional analyses of differentially expressed and differentially methylated genes were done. Selected genes were validated at DNA, RNA, and protein levels. MEASUREMENTS AND MAIN RESULTS DNA methylation status was altered in IPF. IPF samples demonstrated higher DNA methyltransferase expression without observed alterations in global DNA methylation. Genome-wide differences in DNA methylation status and RNA expression were demonstrated by array hybridization. Among the genes whose DNA methylation status and RNA expression were both significantly altered, 16 genes were hypermethylated in DNA associated with decreased mRNA expression or vice versa. We validated CLDN5, ZNF467, TP53INP1, and DDAH1 genes at the level of DNA methylation status, RNA, and protein-level expression. CONCLUSIONS Changes in DNA methylation correspond to altered mRNA expression of a number of genes, some with known and others with previously uncharacterized roles in IPF, suggesting that DNA methylation is important in the pathogenesis of IPF.

[1]  P. Barnes,et al.  Increased production of the potent oxidant peroxynitrite in the lungs of patients with idiopathic pulmonary fibrosis. , 1997, American journal of respiratory and critical care medicine.

[2]  J. Iovanna,et al.  Tumor Protein p53-Induced Nuclear Protein (TP53INP1) Expression in Medullary Thyroid Carcinoma: A Molecular Guide to the Optimal Extent of Surgery? , 2010, World Journal of Surgery.

[3]  M. Ebina,et al.  Altered expression of tight junction molecules in alveolar septa in lung injury and fibrosis. , 2012, American journal of physiology. Lung cellular and molecular physiology.

[4]  J. McPherson,et al.  MethylScreen: DNA methylation density monitoring using quantitative PCR. , 2007, BioTechniques.

[5]  B. Dahal,et al.  The Role of Dimethylarginine Dimethylaminohydrolase in Idiopathic Pulmonary Fibrosis , 2011, Science Translational Medicine.

[6]  E. White,et al.  Hypermethylation of PTGER2 confers prostaglandin E2 resistance in fibrotic fibroblasts from humans and mice. , 2010, The American journal of pathology.

[7]  Naftali Kaminski,et al.  Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis. , 2006, American journal of respiratory and critical care medicine.

[8]  A. Miyajima,et al.  A novel nuclear zinc finger protein EZI enhances nuclear retention and transactivation of STAT3 , 2002, The EMBO journal.

[9]  M. Skinner Role of epigenetics in developmental biology and transgenerational inheritance. , 2011, Birth defects research. Part C, Embryo today : reviews.

[10]  M. Esteller,et al.  Profiling epigenetic alterations in disease. , 2011, Advances in experimental medicine and biology.

[11]  Jin Woo Song,et al.  Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis. , 2009, American journal of respiratory and critical care medicine.

[12]  Yi Qu,et al.  Global profiling of histone and DNA methylation reveals epigenetic-based regulation of gene expression during epithelial to mesenchymal transition in prostate cells , 2010, BMC Genomics.

[13]  C. B. Alexander,et al.  Loss of fibroblast Thy-1 expression correlates with lung fibrogenesis. , 2005, The American journal of pathology.

[14]  G. Laurent,et al.  STAT3-mediated signaling dysregulates lung fibroblast-myofibroblast activation and differentiation in UIP/IPF. , 2012, The American journal of pathology.

[15]  K. Nagai,et al.  The Role of Catalase in Pulmonary Fibrosis , 2010, Respiratory research.

[16]  M. Gleave,et al.  TP53INP1 overexpression in prostate cancer correlates with poor prognostic factors and is predictive of biological cancer relapse , 2012, The Prostate.

[17]  J. Whitsett,et al.  Signaling pathways in the epithelial origins of pulmonary fibrosis , 2010, Cell cycle.

[18]  J. Hagood,et al.  Epigenetic regulation of thy-1 by histone deacetylase inhibitor in rat lung fibroblasts. , 2011, American journal of respiratory cell and molecular biology.

[19]  J. Lasky,et al.  Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. , 2009, American journal of physiology. Lung cellular and molecular physiology.

[20]  M. Gleave,et al.  TP53INP1 as new therapeutic target in castration‐resistant prostate cancer , 2012, The Prostate.

[21]  Y. Soini,et al.  Claudin-1, −2, −3, −4, −5, and −7 in Usual Interstitial Pneumonia and Sarcoidosis , 2009, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[22]  Donghui Li,et al.  Association of CHFR Promoter Methylation with Disease Recurrence in Locally Advanced Colon Cancer , 2011, Clinical Cancer Research.

[23]  J. Hagood,et al.  Enhanced myofibroblastic differentiation and survival in Thy-1(-) lung fibroblasts. , 2007, American journal of respiratory cell and molecular biology.

[24]  S. Phan Fibroblast phenotypes in pulmonary fibrosis. , 2003, American journal of respiratory cell and molecular biology.

[25]  S. Bulun,et al.  Hypermethylation of the CpG Island Spanning From Exon II to Intron III is Associated With Steroidogenic Factor 1 Expression in Stromal Cells of Endometriosis , 2011, Reproductive Sciences.

[26]  A. Bird,et al.  Number of CpG islands and genes in human and mouse. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[27]  D. Lane,et al.  Regulation of the p14ARF promoter by DNA methylation , 2008, Cell cycle.

[28]  Xi Chen,et al.  BVES regulates EMT in human corneal and colon cancer cells and is silenced via promoter methylation in human colorectal carcinoma. , 2011, The Journal of clinical investigation.

[29]  N. Kaminski,et al.  Caveolin-1: a critical regulator of lung fibrosis in idiopathic pulmonary fibrosis , 2006, The Journal of experimental medicine.

[30]  Venkateshwar G. Keshamouni,et al.  PPAR-γ agonists inhibit profibrotic phenotypes in human lung fibroblasts and bleomycin-induced pulmonary fibrosis , 2008 .

[31]  Kohta Ikegami,et al.  Interplay between DNA methylation, histone modification and chromatin remodeling in stem cells and during development. , 2009, The International journal of developmental biology.

[32]  A. Carrier,et al.  Tumor protein 53-induced nuclear protein 1 is a major mediator of p53 antioxidant function. , 2009, Cancer research.

[33]  T. Bestor,et al.  Eukaryotic cytosine methyltransferases. , 2005, Annual review of biochemistry.

[34]  J. Roman,et al.  The Role of PPARs in Lung Fibrosis , 2007, PPAR research.

[35]  S. Zöchbauer-Müller,et al.  Lung cancer: From single-gene methylation to methylome profiling , 2010, Cancer and Metastasis Reviews.

[36]  M. Morosini,et al.  Analysis of bronchoalveolar lavage fluid proteome from systemic sclerosis patients with or without functional, clinical and radiological signs of lung fibrosis , 2006, Arthritis research & therapy.

[37]  G. Nuovo,et al.  Thy-1 promoter hypermethylation: a novel epigenetic pathogenic mechanism in pulmonary fibrosis. , 2008, American journal of respiratory cell and molecular biology.

[38]  Naftali Kaminski,et al.  MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis , 2008, PLoS medicine.

[39]  Christian B. Woods,et al.  Quantitative analysis of associations between DNA hypermethylation, hypomethylation, and DNMT RNA levels in ovarian tumors , 2006, Oncogene.

[40]  François Fuks,et al.  DNA methylation and histone modifications: teaming up to silence genes. , 2005, Current opinion in genetics & development.

[41]  M. Selman,et al.  Idiopathic pulmonary fibrosis: new insights in its pathogenesis. , 2002, The international journal of biochemistry & cell biology.

[42]  T. Martin,et al.  Zinc Finger Protein 467 Is a Novel Regulator of Osteoblast and Adipocyte Commitment* , 2010, The Journal of Biological Chemistry.

[43]  A. Camargo,et al.  Epigenetic Changes of CXCR4 and Its Ligand CXCL12 as Prognostic Factors for Sporadic Breast Cancer , 2011, PloS one.

[44]  F. Martinez,et al.  Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). , 2006, American journal of respiratory and critical care medicine.

[45]  J. Herman,et al.  Gene silencing in cancer in association with promoter hypermethylation. , 2003, The New England journal of medicine.

[46]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[47]  V. Poletti,et al.  Migratory marker expression in fibroblast foci of idiopathic pulmonary fibrosis , 2006, Respiratory research.

[48]  E. Liu,et al.  THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma , 2005, Oncogene.

[49]  D. Morton,et al.  AIM1 and LINE-1 Epigenetic Aberrations In Tumor and Serum Relate to Melanoma Progression and Disease Outcome , 2012, The Journal of investigative dermatology.

[50]  G. Rosen,et al.  SPARC Suppresses Apoptosis of Idiopathic Pulmonary Fibrosis Fibroblasts through Constitutive Activation of β-Catenin* , 2010, The Journal of Biological Chemistry.

[51]  J. Norris,et al.  Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. , 2007, American journal of respiratory and critical care medicine.